We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$591B
AUM Growth
-$94.6B
Cap. Flow
+$3.09B
Cap. Flow %
0.52%
Top 10 Hldgs %
20.46%
Holding
2,656
New
75
Increased
1,551
Reduced
819
Closed
97

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$2.72B
2
BKNG icon
Booking.com
BKNG
+$2.61B
3
RHT
Red Hat Inc
RHT
+$1.62B
4
JPM icon
JPMorgan Chase
JPM
+$1.43B
5
STT icon
State Street
STT
+$1.29B

Sector Composition

Rank Sector Weight
1 Healthcare 18.85%
2 Technology 18.49%
3 Financials 14.29%
4 Consumer Discretionary 14.06%
5 Communication Services 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLBD icon
1051
Blue Bird Corp
BLBD
$2.04B
$26.7M ﹤0.01%
1,467,571
-9,552
-0.6% -$186K
UVE icon
1052
Universal Insurance Holdings
UVE
$1.18B
$26.7M ﹤0.01%
702,870
+302,146
+75% +$13.2M
DXC icon
1053
DXC Technology
DXC
$1.79B
$26.6M ﹤0.01%
501,212
+2,830
+0.6% +$196K
TCX icon
1054
Tucows
TCX
$140M
$26.6M ﹤0.01%
443,639
+5,508
+1% +$308K
ZD icon
1055
Ziff Davis
ZD
$1.92B
$26.6M ﹤0.01%
441,139
+1,482
+0.3% +$93.5K
TCDA
1056
DELISTED
Tricida, Inc. Common Stock
TCDA
$26.4M ﹤0.01%
1,117,839
+116,058
+12% +$3.34M
HWKN icon
1057
Hawkins
HWKN
$2.67B
$26.3M ﹤0.01%
1,282,630
-26,608
-2% -$518K
PVTL
1058
DELISTED
Pivotal Software, Inc.
PVTL
$26.2M ﹤0.01%
1,604,989
+681,203
+74% +$12.2M
WAT icon
1059
Waters Corp
WAT
$40.6B
$26.1M ﹤0.01%
138,255
+10,800
+8% +$2.05M
AGO icon
1060
Assured Guaranty
AGO
$3.29B
$26.1M ﹤0.01%
681,175
-797,932
-54% -$31.9M
ATKR icon
1061
Atkore
ATKR
$3.17B
$26.1M ﹤0.01%
1,313,311
+16,584
+1% +$347K
NTAP icon
1062
NetApp
NTAP
$40.2B
$26M ﹤0.01%
436,293
+1,500
+0.3% +$108K
INSP icon
1063
Inspire Medical Systems
INSP
$1.68B
$26M ﹤0.01%
+615,028
New +$26.1M
CHX
1064
DELISTED
ChampionX
CHX
$25.8M ﹤0.01%
951,883
+66,236
+7% +$2.44M
REX icon
1065
REX American Resources
REX
$1.44B
$25.7M ﹤0.01%
2,263,026
+140,598
+7% +$1.65M
PRTY
1066
DELISTED
Party City Holdco Inc.
PRTY
$25.7M ﹤0.01%
2,572,917
-37,429
-1% -$407K
EXP icon
1067
Eagle Materials
EXP
$6.47B
$25.6M ﹤0.01%
420,109
-49,808
-11% -$3.57M
SUPN icon
1068
Supernus Pharmaceuticals
SUPN
$2.74B
$25.5M ﹤0.01%
767,588
-6,733
-0.9% -$290K
PLOW icon
1069
Douglas Dynamics
PLOW
$981M
$25.4M ﹤0.01%
707,555
-5,702
-0.8% -$224K
SNA icon
1070
Snap-on
SNA
$21.1B
$25.4M ﹤0.01%
174,555
-309,948
-64% -$49M
OVV icon
1071
Ovintiv
OVV
$17.5B
$25.3M ﹤0.01%
873,862
-849,762
-49% -$36.6M
PODD icon
1072
Insulet
PODD
$10.1B
$25M ﹤0.01%
315,611
-50,583
-14% -$4.28M
JAZZ icon
1073
Jazz Pharmaceuticals
JAZZ
$16B
$25M ﹤0.01%
201,562
+4,338
+2% +$644K
PRNB
1074
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$25M ﹤0.01%
911,972
+44,913
+5% +$1.16M
PDFS icon
1075
PDF Solutions
PDFS
$2.19B
$24.9M ﹤0.01%
2,953,303
+22,234
+0.8% +$189K

Similar funds

T. Rowe Price Associates's Q4 2018 Portfolio in Review

As of Q4 2018, T. Rowe Price Associates held 2,656 positions worth $591B, down 14% from $685B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

T. Rowe Price Associates's Q4 2018 filing shows 75 new, 1,551 increased, 819 reduced and 97 closed positions. Its largest new stake was StoneCo: 28,883,228 shares worth $519M. The largest sale was Tesla, an estimated $2.72B.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Financials.

  • T. Rowe Price Associates's largest Q4 2018 buy was StoneCo: 28,883,228 shares worth $519M.
  • T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q4 2018, an estimated $2.16B increase.
  • T. Rowe Price Associates's biggest Q4 2018 reduction was Tesla, cutting an estimated $2.72B.
  • T. Rowe Price Associates fully exited Aetna Inc in Q4 2018, selling an estimated $600M.
  • T. Rowe Price Associates's ten largest holdings make up 20% of its $591B portfolio in Q4 2018.
  • T. Rowe Price Associates opened 75 new positions and closed 97 in Q4 2018.
  • T. Rowe Price Associates's portfolio value fell 14% quarter-over-quarter to $591B.

Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.